Regulatory approval for new innovative medicine and devices remains a life-threatening challenge to the industry. Join the 3rd Annual MedTech Reimbursement Roundtable discussion on market access for products (reimbursement and payer evidence) for regulatory professionals.
While the market access function has emerged for about a decade, the essence of it is alien to most regulatory professionals in the industry, who may be focused on R&D, clinical and regulatory development of the product.
Market access is a new and essential skillset that should be brought on board for every company trying to make its innovation a commercial success in the market. It is imperative to train regulatory leaders to understand the implications of upcoming market access hurdles (reimbursement, pricing and coverage policy) early on in the development phase. This allows for alignment with market access objectives from the beginning, so the work, investment and resources don’t disappear with no buyer (or payer) for the product.
Download the Agenda Here
Key topics: